ClinicalTrials.Veeva

Menu

PEEP FOR LUNG RECRUITMENT IN PRETERM INFANTS-EIT STUDY ([PEOPLE])

S

South Tees Hospitals NHS Foundation Trust

Status

Not yet enrolling

Conditions

Lung Recruitment
Positive End Expiratory Pressure (PEEP)
PreTerm Neonate
Electrical Impedance Tomography (EIT)

Treatments

Diagnostic Test: Studying the effects of varying levels of PEEP using Electrical impedance tomography

Study type

Interventional

Funder types

Other

Identifiers

NCT06705257
IRAS [340081] - [PEOPLE]

Details and patient eligibility

About

Babies born early (under 32 weeks) are at risk of developing lung problems after birth. A major reason for this is that the lungs are not fully developed. Lungs of preterm babies will often collapse in between breathing due to lung immaturity. Applying gentle pressure, using nasal device through their nostril or through the breathing tube helps to prevent this lung collapse. This would help in air-oxygen going to lungs and also makes the babies breathing more comfortable. This gentle pressure is medically called as PEEP/CPAP and could be delivered by breathing machine (ventilator) and CPAP machine, collectively called as "continuous distending pressure (CDP)".

Those babies breathing on their own and receiving inadequate CDP would need more breathing support by placing them on breathing machine (ventilator). The longer the baby receives breathing machine support, higher chance of lung injury . Preterm infants who are already on breathing machine, providing sub optimal PEEP/CPAP could also lead to lung damage. Providing optimal PEEP/CPAP could prevent these negative outcomes. Currently there is not enough evidence to suggest optimal PEEP/CPAP in preterm infants. Neonatal units all around the world uses PEEP/CPAP ranging from 4 to 10cm H20 based on their unit practice. Currently available investigations provide limited one time information (e.g. Chest X-ray) regarding whether baby is receiving optimal PEEP/CPAP. Electrical Impedance Tomography (EIT) is a new technology which could provide better information regarding the pressure delivered. Also, this device would provide continuous information as if the clinicians are doing continuous chest X-ray but without any radiation. In this study, the team will assess the effect of different levels of PEEP/CPAP (4 to 10cm H20) on prevention of lung collapse using EIT. This would be studied in premature infants who are on breathing machine support and CPAP machine support.

Enrollment

30 estimated patients

Sex

All

Ages

22 to 32 weeks old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  1. Gestational age <32 weeks based on mother's last menstrual period or first trimester ultrasound dating.
  2. Receiving either CPAP or mechanical ventilation respiratory support.
  3. Informed written consent from one of the parents.
  4. Within the first two weeks of life. Investigators pragmatically chose this period, as there could be considerable lung injury after the first two weeks of life, making it difficult to test our hypothesis. Also, this time period would allow parents to settle down with their stressful preterm delivery and investigators could approach anytime within the first two weeks of life.

Exclusion criteria

  1. Major congenital malformations including congenital lung disease and congenital heart disease as ascertained by the medical team.
  2. Infants diagnosed with pneumothorax i.
  3. Receiving high frequency mechanical ventilation.
  4. Infants with concerns of skin integrity.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Single arm with increasing and decreasing PEEP levels
Experimental group
Treatment:
Diagnostic Test: Studying the effects of varying levels of PEEP using Electrical impedance tomography

Trial contacts and locations

0

Loading...

Central trial contact

Prakash Kannan Loganathan, MD; Amanda Forster

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems